Abstract
The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.
| Original language | Italian |
|---|---|
| Pages (from-to) | 148-152 |
| Number of pages | 5 |
| Journal | Annali di Ostetricia Ginecologia Medicina Perinatale |
| Volume | 103 |
| Issue number | 2 |
| Publication status | Published - 1982 |
Fingerprint
ASJC Scopus subject areas
- Obstetrics and Gynaecology
Cite this
VALUTAZIONE DELLE ROSETTE E IN PAZIENTI PORTATRICI DI CARCINOMA ENDOMETRIALE. (STUDIO LONGITUDINALE DI 43 CASI). / Bolis, P. F.; Guaschino, S.; Franchi, M.; Maccario, R.
In: Annali di Ostetricia Ginecologia Medicina Perinatale, Vol. 103, No. 2, 1982, p. 148-152.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - VALUTAZIONE DELLE ROSETTE E IN PAZIENTI PORTATRICI DI CARCINOMA ENDOMETRIALE. (STUDIO LONGITUDINALE DI 43 CASI)
AU - Bolis, P. F.
AU - Guaschino, S.
AU - Franchi, M.
AU - Maccario, R.
PY - 1982
Y1 - 1982
N2 - The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.
AB - The percentage of Rosette E does not show significant modification in the patients affected with adenocarcinoma of endometrium stage I and II in comparison with a control group. We did not find any modification at the diagnosis, during the follow-up, considering the stage, the cellular differentiation, the myometrial infiltration and the presence or absence of relapses. We think that the endometrial carcinoma can originate and progress independently from the immunological situation of the patient, or that the Rosette E are not a significant prognostic index for this tumor.
UR - http://www.scopus.com/inward/record.url?scp=0020318276&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020318276&partnerID=8YFLogxK
M3 - Articolo
C2 - 6981371
AN - SCOPUS:0020318276
VL - 103
SP - 148
EP - 152
JO - Annali di Ostetricia Ginecologia Medicina Perinatale
JF - Annali di Ostetricia Ginecologia Medicina Perinatale
SN - 0003-4657
IS - 2
ER -